Bodycote 4-Month Revenues Down Organically; Sees FY25 Outlook In Line With Market

Bodycote Plc reported a 6% organic revenue decrease for the four months ending April 30, with its core business down 5% due to tough prior-year comparisons and lower energy surcharges. While Civil Aerospace and Defence sectors showed improvement, Automotive and Industrial Markets remain challenging. The company maintains its full-year outlook, projecting revenue of £718 million and operating profit of £121.5 million, with adjusted operating profit in 2025 expected to be second-half weighted due to benefits from 'Optimise' and new contracts.

Analysis

Bodycote Plc reported a challenging start to the year, with group revenue for the four months to April 30 declining 6% organically to £246 million compared to the prior year. This was primarily driven by a 5% organic decrease in its core business, attributed to a strong prior-year comparator and a 1% headwind from lower energy surcharges. Specialist Technologies saw a more significant 11% organic revenue drop, while Precision Heat Treatment revenue fell 2% organically. Despite these declines, the company noted positive developments, including improved supply chain conditions and accelerating demand in Civil Aerospace, particularly in March and April, and continued growth in Defence, led by Western Europe. Conversely, Automotive and Industrial markets remain difficult. Bodycote has reaffirmed its full-year outlook, aligning with market expectations of £718 million in revenue and £121.5 million in operating profit. Looking to 2025, adjusted operating profit is anticipated to be weighted towards the second half, contingent on the progressive delivery of benefits from its "Optimise" program, new contracts in Defence and Oil & Gas within Specialist Technologies, and further growth in Aerospace & Defence. The company is actively monitoring global trade discussions and tariffs, stating no material direct exposure, and is focused on operational delivery and cost control amidst an uncertain macroeconomic environment, reflecting a cautious overall tone.

Key Decisions for Investors

• Investors should closely monitor Bodycote's ability to navigate the challenging Automotive and Industrial markets and achieve its reaffirmed full-year guidance, given the reported 6% organic revenue decline in the first four months.
• The anticipated second-half weighting of adjusted operating profit in 2025, driven by the "Optimise" program and new contracts in Specialist Technologies (Defence, Oil & Gas) alongside continued Aerospace & Defence growth, presents key catalysts to watch for potential recovery and margin improvement.
• Given the mixed performance across sectors and the stated uncertain macroeconomic environment, investors should carefully assess the execution risk related to the "Optimise" benefits and the company's capacity to manage ongoing cost pressures and market headwinds effectively.